Skip to main content
Figure 2 | Malaria Journal

Figure 2

From: Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study

Figure 2

Clinical course of the disease and parasitaemia levels. A: Cumulative SHIRPA score of GA (open bars) and vehicle (filled bars) treated animals on day 0, 5, 11 post-infection and in moribund animals with CM. B: Course of parasitaemia of GA (open bars) and vehicle (filled bars) treated animals. No significant differences were found in the respective values of the SHIRPA score and parasitaemia between GA and vehicle treated animals. Mean values and SEM are shown.

Back to article page